These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3937500)

  • 21. [Pharmacokinetics of calcium antagonists].
    Richard MO
    Therapie; 1993; 48 Spec No():651-7. PubMed ID: 8091350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of bepridil and diltiazem on [3H]nitrendipine binding to canine cardiac sarcolemma. Potentiation of pharmacological effects of nitrendipine by bepridil.
    Balwierczak JL; Grupp IL; Grupp G; Schwartz A
    J Pharmacol Exp Ther; 1986 Apr; 237(1):40-8. PubMed ID: 2937911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of diltiazem and other calcium entry blockers.
    Hermann P; Morselli PL
    Acta Pharmacol Toxicol (Copenh); 1985; 57 Suppl 2():10-20. PubMed ID: 3904330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic uses of calcium-blocking agents:verapamil, nifedipine, and diltiazem.
    Schwartz DJ; Wasserstrom JA; Fozzard HA
    Compr Ther; 1981 Oct; 7(10):25-33. PubMed ID: 7297044
    [No Abstract]   [Full Text] [Related]  

  • 25. Ca2+ uptake and energy supply of sheep heart mitochondria in presence of some calcium antagonists.
    Leblondel G; Allain P
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):499-502. PubMed ID: 6611569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Ca2+-antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil, on platelet aggregation in vitro.
    Ono H; Kimura M
    Arzneimittelforschung; 1981; 31(7):1131-4. PubMed ID: 7196762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacology of calcium antagonists: a critical review.
    Eichelbaum M; Echizen H
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S963-7. PubMed ID: 6085385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of calcium channel blockers on NIH 3T3 fibroblasts expressing the Ha-ras oncogene.
    Dartsch PC; Ritter M; Gschwentner M; Lang HJ; Lang F
    Eur J Cell Biol; 1995 Aug; 67(4):372-8. PubMed ID: 8521877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacology of calcium antagonists].
    Zannad F
    Rev Prat; 1988 Nov; 38(27):1965-70. PubMed ID: 3264617
    [No Abstract]   [Full Text] [Related]  

  • 30. Differential actions of calcium antagonists on calcium binding to cardiac sarcolemma.
    Pang DC; Sperelakis N
    Eur J Pharmacol; 1982 Jul; 81(3):403-9. PubMed ID: 6981516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (+/-)bepridil and (-)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes.
    Galizzi JP; Fosset M; Lazdunski M
    Biochem Biophys Res Commun; 1985 Oct; 132(1):49-55. PubMed ID: 2998366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ca(2+)-channel blockers and nucleoside triphosphate diphosphohydrolase (NTPDase) influence of diltiazem, nifedipine, and verapamil.
    Gendron FP; Latour JG; Gravel D; Wang Y; Beaudoin AR
    Biochem Pharmacol; 2000 Dec; 60(12):1959-65. PubMed ID: 11108813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of nicardipine following oral and intravenous administration in man.
    Graham DJ; Dow RJ; Freedman D; Mroszczak E; Ling T
    Postgrad Med J; 1984; 60 Suppl 4():7-10. PubMed ID: 6527979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of nitrendipine in patients with renal failure: comparison to normal subjects.
    Aronoff GR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S974-6. PubMed ID: 6085387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interaction between calcium antagonists and digoxin].
    Christensen C
    Ugeskr Laeger; 1991 Apr; 153(17):1180-4. PubMed ID: 2028527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetics and -dynamics of calcium antagonists in the elderly].
    Spahn-Langguth H; Möhrke W; Mutschler E; Platt D
    Fortschr Med; 1993 Oct; 111(28):441-5. PubMed ID: 8282288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiological effects of bepridil and its quaternary derivative CERM 11888 in closed chest anaesthetized dogs: a comparison with verapamil and diltiazem.
    Leboeuf J; Lamar JC; Massingham R; Ponsonnaille J
    Br J Pharmacol; 1989 Dec; 98(4):1351-9. PubMed ID: 2611495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nifedipine and diltiazem but not verapamil up-regulate endothelial nitric-oxide synthase expression.
    Ding Y; Vaziri ND
    J Pharmacol Exp Ther; 2000 Feb; 292(2):606-9. PubMed ID: 10640297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of anti-ischemic effect of bepridil and diltiazem evaluated by exercise test in patients with coronary disease. A multicenter study. Groupe d'Investigateurs].
    Sellier P; Quilliet L
    Ann Cardiol Angeiol (Paris); 1997 Nov; 46(9):602-8. PubMed ID: 9538375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of nifedipine, verapamil and diltiazem on serum biochemical parameters and aortic composition of atherosclerotic chickens.
    García-Pérez B; Ayala I; Castells MT; Doménech G; Sánchez-Polo MT; García-Partida P; Valdés M
    Biomed Pharmacother; 2005; 59(1-2):1-7. PubMed ID: 15740928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.